Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Recombinant Protein Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Protein Vaccinemarket, defines the market attractiveness level of Recombinant Protein Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Recombinant Protein Vaccine industry, describes the types of Recombinant Protein Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Protein Vaccine market and the development prospects and opportunities of Recombinant Protein Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Protein Vaccine market in Chapter 13.
By Player:
Medicago
Zoties
Novavax
Plumbline Life Sciences
Boehringer-Ingelheim
GSK
Indian Immunologicals
Elanco
Sanofi
By Type:
Bacterial Cells Culture
Mammalian Cells Culture
By End-User:
Human
Animal
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Recombinant Protein Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Recombinant Protein Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Recombinant Protein Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Recombinant Protein Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Recombinant Protein Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Recombinant Protein Vaccine Consumption (2017-2022)
-
7.2 United States Recombinant Protein Vaccine Consumption (2017-2022)
-
7.3 Europe Recombinant Protein Vaccine Consumption (2017-2022)
-
7.4 China Recombinant Protein Vaccine Consumption (2017-2022)
-
7.5 Japan Recombinant Protein Vaccine Consumption (2017-2022)
-
7.6 India Recombinant Protein Vaccine Consumption (2017-2022)
-
7.7 South Korea Recombinant Protein Vaccine Consumption (2017-2022)
8 Region and Country-wise Recombinant Protein Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.4 China Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.6 India Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Recombinant Protein Vaccine Consumption Forecast (2022-2028)
9 Global Recombinant Protein Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Recombinant Protein Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bacterial Cells Culture Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mammalian Cells Culture Consumption and Growth Rate (2017-2022)
-
9.2 Global Recombinant Protein Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Human Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Animal Consumption and Growth Rate (2017-2022)
10 Global Recombinant Protein Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bacterial Cells Culture Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mammalian Cells Culture Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Human Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Animal Consumption Forecast and Growth Rate (2022-2028)
11 Global Recombinant Protein Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Recombinant Protein Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Recombinant Protein Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Recombinant Protein Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Recombinant Protein Vaccine Market Competitive Analysis
-
14.1 Medicago
-
14.1.1 Medicago Company Details
-
14.1.2 Medicago Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Medicago Recombinant Protein Vaccine Product and Service
-
14.2 Zoties
-
14.2.1 Zoties Company Details
-
14.2.2 Zoties Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zoties Recombinant Protein Vaccine Product and Service
-
14.3 Novavax
-
14.3.1 Novavax Company Details
-
14.3.2 Novavax Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novavax Recombinant Protein Vaccine Product and Service
-
14.4 Plumbline Life Sciences
-
14.4.1 Plumbline Life Sciences Company Details
-
14.4.2 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Plumbline Life Sciences Recombinant Protein Vaccine Product and Service
-
14.5 Boehringer-Ingelheim
-
14.5.1 Boehringer-Ingelheim Company Details
-
14.5.2 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer-Ingelheim Recombinant Protein Vaccine Product and Service
-
14.6 GSK
-
14.6.1 GSK Company Details
-
14.6.2 GSK Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GSK Recombinant Protein Vaccine Product and Service
-
14.7 Indian Immunologicals
-
14.7.1 Indian Immunologicals Company Details
-
14.7.2 Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Indian Immunologicals Recombinant Protein Vaccine Product and Service
-
14.8 Elanco
-
14.8.1 Elanco Company Details
-
14.8.2 Elanco Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Elanco Recombinant Protein Vaccine Product and Service
-
14.9 Sanofi
-
14.9.1 Sanofi Company Details
-
14.9.2 Sanofi Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi Recombinant Protein Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Recombinant Protein Vaccine
-
Figure Recombinant Protein Vaccine Picture
-
Table Global Recombinant Protein Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Protein Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Recombinant Protein Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Recombinant Protein Vaccine Consumption by Country (2017-2022)
-
Figure United States Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bacterial Cells Culture Consumption and Growth Rate (2017-2022)
-
Figure Global Mammalian Cells Culture Consumption and Growth Rate (2017-2022)
-
Figure Global Human Consumption and Growth Rate (2017-2022)
-
Figure Global Animal Consumption and Growth Rate (2017-2022)
-
Figure Global Bacterial Cells Culture Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mammalian Cells Culture Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Animal Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Recombinant Protein Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Recombinant Protein Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Medicago (Foundation Year, Company Profile and etc.)
-
Table Medicago Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medicago Recombinant Protein Vaccine Product and Service
-
Table Zoties (Foundation Year, Company Profile and etc.)
-
Table Zoties Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zoties Recombinant Protein Vaccine Product and Service
-
Table Novavax (Foundation Year, Company Profile and etc.)
-
Table Novavax Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novavax Recombinant Protein Vaccine Product and Service
-
Table Plumbline Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Plumbline Life Sciences Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Plumbline Life Sciences Recombinant Protein Vaccine Product and Service
-
Table Boehringer-Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer-Ingelheim Recombinant Protein Vaccine Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Recombinant Protein Vaccine Product and Service
-
Table Indian Immunologicals (Foundation Year, Company Profile and etc.)
-
Table Indian Immunologicals Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indian Immunologicals Recombinant Protein Vaccine Product and Service
-
Table Elanco (Foundation Year, Company Profile and etc.)
-
Table Elanco Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elanco Recombinant Protein Vaccine Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Recombinant Protein Vaccine Product and Service
-
